Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bozzali, M.
Right arrow Articles by Falini, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bozzali, M.
Right arrow Articles by Falini, A.
Related Collections
Right arrow MRI
Right arrow Volumetric MRI
Right arrow Bacterial infections
NEUROLOGY 2006;67:453-460
© 2006 American Academy of Neurology

The contribution of voxel-based morphometry in staging patients with mild cognitive impairment

M. Bozzali, MD, M. Filippi, MD, G. Magnani, MD, M. Cercignani, MPhil, M. Franceschi, MD, E. Schiatti, MD, S. Castiglioni, Psych, R. Mossini, MD, M. Falautano, Psych, G. Scotti, MD, G. Comi, MD and A. Falini, MD

From the Neuroimaging Research Unit (M.B., M. Filippi, M.C.), Department of Neurology (M. Filippi, G.M., E.S., R.M., M. Falautano, G.C.), and Department of Neuroradiology, CERMAC (G.S., A.F.), Scientific Institute and University Ospedale San Raffaele, Milan, Italy; Wellcome Department of Imaging Neuroscience (M.B.) and NMR Research Unit (M.C.), Institute of Neurology, University College of London, London, UK; and Department of Neurology, Multimedica-SantaMaria, Castellanza, Italy (M. Franceschi, S.C.).

Address correspondence and reprint requests to Dr. Marco Bozzali, Wellcome Department of Imaging Neuroscience, Institute of Neurology, University College of London, 12 Queen Square, WC1N 3BG London, UK; e-mail: m.bozzali{at}fil.ion.ucl.ac.uk

Objective: To assess whether different patterns of regional gray matter loss in patients with mild cognitive impairment (MCI) are associated with different risks of conversion to Alzheimer disease (AD), using MRI and voxel-based morphometry (VBM).

Methods: The authors recruited 22 patients with MCI, 22 patients with probable AD, and 20 healthy subjects (HS). T1 volumes from each subject were postprocessed according to an optimized VBM protocol. All patients were clinically followed up (mean [SD] time = 28.7 [5.7] months), and patients with MCI were reclassified into two groups (converters and nonconverters to AD).

Results: When comparing patients with AD to HS, widespread areas of reduced gray matter density were found predominantly in temporal, frontal, and parietal lobes and in the insula. Comparing MCI converters and nonconverters with HS, the converters showed more widespread areas of reduced gray matter density than nonconverters, with a pattern of abnormalities similar to that seen in patients with AD. Conversely, when comparing the same groups with patients with AD, MCI nonconverters showed a pattern of gray matter density similar to that of HS. Areas of decreased gray matter density were also found in MCI converters compared with nonconverters.

Conclusions: Different patterns of gray matter density distribution in patients with mild cognitive impairment may be associated to different rates of conversion to Alzheimer disease.


Disclosure: The authors report no conflicts of interest.

Received October 18, 2005. Accepted in final form April 4, 2006.




This article has been cited by other articles:


Home page
Cereb CortexHome page
B. C. Dickerson, A. Bakkour, D. H. Salat, E. Feczko, J. Pacheco, D. N. Greve, F. Grodstein, C. I. Wright, D. Blacker, H. D. Rosas, et al.
The Cortical Signature of Alzheimer's Disease: Regionally Specific Cortical Thinning Relates to Symptom Severity in Very Mild to Mild AD Dementia and is Detectable in Asymptomatic Amyloid-Positive Individuals
Cereb Cortex, July 16, 2008; (2008) bhn113v1.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. L. Whitwell, M. M. Shiung, S. A. Przybelski, S. D. Weigand, D. S. Knopman, B. F. Boeve, R. C. Petersen, and C. R. Jack Jr
MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment
Neurology, February 12, 2008; 70(7): 512 - 520.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. S. Fleisher, S. Sun, C. Taylor, C. P. Ward, A. C. Gamst, R. C. Petersen, C. R. Jack Jr, P. S. Aisen, L. J. Thal, and For the Alzheimer's Disease Cooperative Study
Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment
Neurology, January 15, 2008; 70(3): 191 - 199.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
L. G. Apostolova, C. A. Steiner, G. G. Akopyan, R. A. Dutton, K. M. Hayashi, A. W. Toga, J. L. Cummings, and P. M. Thompson
Three-Dimensional Gray Matter Atrophy Mapping in Mild Cognitive Impairment and Mild Alzheimer Disease
Arch Neurol, October 1, 2007; 64(10): 1489 - 1495.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
J. L. Whitwell, S. A. Przybelski, S. D. Weigand, D. S. Knopman, B. F. Boeve, R. C. Petersen, and C. R. Jack Jr
3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease
Brain, July 1, 2007; 130(7): 1777 - 1786.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
M. Filippi, F. Agosta, and M. A. Rocca
Regional Assessment of Brain Atrophy: A Novel Approach to Achieve a More Complete Picture of Tissue Damage Associated with Central Nervous System Disorders?
AJNR Am. J. Neuroradiol., February 1, 2007; 28(2): 260 - 261.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by AAN Enterprises, Inc.